EIR Wyeth Pharmaceutical Division of Wyeth Holdings Jan 2002

Susan Laska FDA, Omotunde Osunsanmi FDA, Simone Pitts FDA, Matthew Spataro FDA, Richard Thornton FDA$595.00 - Available Now

FDA investigators audited the Wyeth Pharmaceutical Division of Wyeth Holdings - Pearl River, NY, United States facility and issued inspectional observation (via FDA 483) on 24 Jan 2002.

Product details

  • Category:
  • Inspection end: 24 Jan 2002
  • Location: Pearl River, United States
  • FEI: 2410662
Add To Cart